Hydrophilic silica aerogels as dermal drug delivery systems – Dithranol as a model drug

2008 ◽  
Vol 69 (3) ◽  
pp. 935-942 ◽  
Author(s):  
U GUENTHER ◽  
I SMIRNOVA ◽  
R NEUBERT
Keyword(s):  
Drug Delivery ◽  
Drug Delivery Systems ◽  
Silica Aerogels ◽  
Delivery Systems ◽  
Model Drug ◽  
Dermal Drug Delivery

scholarly journals Cellulose nanofiber–titania nanocomposites as potential drug delivery systems for dermal applications

2015 ◽  
Vol 3 (8) ◽  
pp. 1688-1698 ◽  
Author(s):  
O. L. Galkina ◽  
V. K. Ivanov ◽  
A. V. Agafonov ◽  
G. A. Seisenbaeva ◽  
V. G. Kessler
Keyword(s):  
Drug Delivery ◽  
Controlled Release ◽  
Active Ingredient ◽  
Drug Delivery Systems ◽  
Delivery Systems ◽  
Cellulose Nanofiber ◽  
Potential Drug ◽  
Model Drug ◽  
Dermal Drug Delivery

Nanocomposites with potential for dermal drug delivery have been developed using nanotitania chemically grafted onto nanocellulose as an active ingredient for enhanced uptake and controlled release of model drug loads.

scholarly journals Fabrication of Sharp Tip-Separable Microneedle Device for Trans-Dermal Drug Delivery Systems

Proceedings ◽  
2017 ◽  
Vol 1 (4) ◽  
pp. 304 ◽  
Author(s):  
Yuki Nabekura ◽  
Hitoshi Fukuyu ◽  
Yoshihiro Hasegawa ◽  
Mitsuhiro Shikida
Keyword(s):  
Drug Delivery ◽  
Drug Delivery Systems ◽  
Delivery Systems ◽  
Dermal Drug Delivery

Coumarin 6 as a fluorescent model drug: How to identify properties of lipid colloidal drug delivery systems via fluorescence spectroscopy?

2014 ◽  
Vol 116 (9) ◽  
pp. 1234-1246 ◽  
Author(s):  
Jan Henrik Finke ◽  
Claudia Richter ◽  
Thomas Gothsch ◽  
Arno Kwade ◽  
Stephanus Büttgenbach ◽  
...  
Keyword(s):  
Drug Delivery ◽  
Fluorescence Spectroscopy ◽  
Drug Delivery Systems ◽  
Delivery Systems ◽  
Model Drug ◽  
Coumarin 6

scholarly journals A Novel Hybrid Additive Manufacturing Process for Drug Delivery Systems with Locally Incorporated Drug Depots

Pharmaceutics ◽  
2019 ◽  
Vol 11 (12) ◽  
pp. 661 ◽  
Author(s):  
Jan Konasch ◽  
Alexander Riess ◽  
Robert Mau ◽  
Michael Teske ◽  
Natalia Rekowska ◽  
...  
Keyword(s):  
Drug Delivery ◽  
Additive Manufacturing ◽  
Inkjet Printing ◽  
Drug Delivery Systems ◽  
Delivery Systems ◽  
Blue Dye ◽  
Glycol Diacrylate ◽  
Coomassie Blue ◽  
The Matrix ◽  
Model Drug

Here, we present a new hybrid additive manufacturing (AM) process to create drug delivery systems (DDSs) with selectively incorporated drug depots. The matrix of a DDS was generated by stereolithography (SLA), whereas the drug depots were loaded using inkjet printing. The novel AM process combining SLA with inkjet printing was successfully implemented in an existing SLA test setup. In the first studies, poly(ethylene glycol) diacrylate-based specimens with integrated depots were generated. As test liquids, blue and pink ink solutions were used. Furthermore, bovine serum albumin labeled with Coomassie blue dye as a model drug was successfully placed in a depot inside a DDS. The new hybrid AM process makes it possible to place several drugs independently of each other within the matrix. This allows adjustment of the release profiles of the drugs depending on the size as well as the position of the depots in the DDS.

J2220206 Fabrication of tip-separable microneedles for trans-dermal drug delivery systems

2015 ◽  
Vol 2015 (0) ◽  
pp. _J2220206--_J2220206-
Author(s):  
Kodai IMAEDA ◽  
Katsuhiko BESSHO ◽  
Chikara MIYAKE ◽  
Mitsuhiro SHIKIDA
Keyword(s):  
Drug Delivery ◽  
Drug Delivery Systems ◽  
Delivery Systems ◽  
Dermal Drug Delivery
Sign in / Sign up

Export Citation Format

Share Document